Dr. Sanjib Das

Employment

• Sister Nivedita University Assistant Professor
  2024 - Present

Education

• Jadavpur University Department of Pharmaceutical Technology M. Pharm. (Pharmaceutical Chemistry)
  2016 - 2018
• Maulana Abul Kalam Azad University of Technology, West Bengal
  2013 - 2016

Projects & Funding

Projects & funding information is unavailable.

Publications (20)

• An overview of matrix metalloproteinase-12 in multiple disease conditions, potential selective inhibitors, and drug designing strategies
  European Journal of Medicinal Chemistry 2025 DOI: 10.1016/j.ejmech.2024.117154
  +Save
• Derivatives of D(−)-glutamine-based MMP-2 inhibitors as an effective remedy for the management of chronic myeloid leukemia-Part-III: Synthesis, biological screening and in silico binding interaction analysis
  Bioorganic Chemistry 2025 DOI: 10.1016/j.bioorg.2024.108057
  +Save
• Synthesis, biological assessment, and in silico binding mode interaction analyses and DFT studies of biphenylsulfonamide-based potent MMP-2 inhibitors effective against chronic myeloid leukemia
  Journal of Molecular Structure 2025 DOI: 10.1016/j.molstruc.2024.141278
  +Save
• Biphenylsulfonamides as effective MMP‐2 inhibitors with promising antileukemic efficacy: Synthesis, in vitro biological evaluation, molecular docking, and MD simulation analysis
  Drug Development Research 2024 DOI: 10.1002/ddr.22255
  +Save
• Derivatives of D(−) glutamine-based MMP-2 inhibitors as an effective remedy for the management of chronic myeloid leukemia-Part-I: Synthesis, biological screening and in silico binding interaction analysis
  European Journal of Medicinal Chemistry 2024 DOI: 10.1016/j.ejmech.2024.116563
  +Save
• A detail survey and analysis of selectivity criteria for indole-based histone deacetylase 8 (HDAC8) inhibitors
  Journal of Molecular Structure 2023 DOI: 10.1016/j.molstruc.2022.133967
  +Save
• Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)?
  European Journal of Medicinal Chemistry 2023 DOI: 10.1016/j.ejmech.2023.115594
  +Save
• In-house glutamine based compound loaded poly-(D-L-lactide-coglycolide) nanoparticles as a possible candidate for the management of chronic myeloid leukemia
  Materials Today: Proceedings 2023 DOI: 10.1016/j.matpr.2023.10.158
  +Save
• Other Modeling Approaches
  Modeling Inhibitors of Matrix Metalloproteinases 2023 DOI: 10.1201/9781003303282-4
  +Save
• Gelatinases and Their Inhibitors
  Modeling Inhibitors of Matrix Metalloproteinases 2023 DOI: 10.1201/9781003303282-7
  +Save